Harrow (HROW) Change in Receivables (2014 - 2026)
Harrow (HROW) recorded quarterly Change in Receivables of -$9.8 million in Q1 2026, down 129.6% quarter-over-quarter from $33.2 million in Q4 2025, and up 74.92% on a YoY basis from -$5.6 million in Q1 2025.
Harrow (HROW) Change in Receivables (2014 - 2026) Analysis & Trends
Harrow's Change in Receivables history runs 13 years deep, the most recent figure standing at -$9.8 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 74.92% year-over-year to -$9.8 million; the TTM figure through Mar 2026 stood at $24.4 million (down 50.73% YoY), while the FY2025 annual figure was -$5.0 million, down 106.24% from the prior year.
- Change in Receivables was -$9.8 million for Q1 2026 at Harrow, down from $33.2 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $62.8 million in Q4 2024 to a low of -$39.2 million in Q1 2025.
- Historically, Change in Receivables has averaged $5.7 million across 5 years, with a median of $1.5 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables soared 5080.0% in 2023, then sank 366.84% in 2025.
- A 5-year view of Change in Receivables shows it stood at -$449000.0 in 2022, then surged by 4121.6% to $18.1 million in 2023, then jumped by 247.67% to $62.8 million in 2024, then plunged by 47.09% to $33.2 million in 2025, then slumped by 129.6% to -$9.8 million in 2026.
- The last three Change in Receivables figures came in at -$9.8 million (Q1 2026), $33.2 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | -9.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.83 Mn |
| Mar 31, 2026 | -9.83 Mn |
| Dec 31, 2025 | 33.22 Mn |
| Dec 31, 2025 | 33.22 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | -39.20 Mn |
| Mar 31, 2025 | -39.20 Mn |
| Dec 31, 2024 | 62.78 Mn |
| Dec 31, 2024 | 62.78 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 24.03 Mn |
| Jun 30, 2024 | 24.03 Mn |
| Mar 31, 2024 | -8.40 Mn |
| Mar 31, 2024 | -8.40 Mn |
| Dec 31, 2023 | 18.06 Mn |
| Dec 31, 2023 | 18.06 Mn |